Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
30.34
+0.82 (2.78%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Arcus Biosciences Employees
Arcus Biosciences had 601 employees as of December 31, 2025. The number of employees decreased by 26 or -4.15% compared to the previous year.
Employees
601
Change (1Y)
-26
Growth (1Y)
-4.15%
Revenue / Employee
$194,676
Profits / Employee
-$765,391
Market Cap
3.86B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 601 | -26 | -4.15% |
| Dec 31, 2024 | 627 | 50 | 8.67% |
| Dec 31, 2023 | 577 | 77 | 15.40% |
| Dec 31, 2022 | 500 | 134 | 36.61% |
| Dec 31, 2021 | 366 | 130 | 55.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,965 |
| Telix Pharmaceuticals | 1,184 |
| Iovance Biotherapeutics | 975 |
| AbCellera Biologics | 562 |
| Denali Therapeutics | 507 |
| Structure Therapeutics | 281 |
| Relay Therapeutics | 202 |
| IDEAYA Biosciences | 145 |
RCUS News
- 10 days ago - Arcus Biosciences Announces New Employment Inducement Grants - Business Wire
- 11 days ago - Arcus Biosciences price target raised to $23 from $22 at Morgan Stanley - TheFly
- 14 days ago - Arcus Biosciences price target raised to $42 from $34 at Goldman Sachs - TheFly
- 15 days ago - Arcus Biosciences price target raised to $43 from $41 at Wedbush - TheFly
- 15 days ago - Arcus Biosciences price target raised to $26 from $23 at Wells Fargo - TheFly
- 16 days ago - Arcus Biosciences reports Q2 EPS (72c), consensus (81c) - TheFly
- 16 days ago - Arcus Biosciences Earnings Call Transcript: Q2 2026 - Transcripts
- 16 days ago - Arcus Biosciences Earnings release: Q2 2026 - Filings